Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earum Pharmaceuticals has informed that the Company has fixed Thursday, 5th October, 2023 as the Record Date, for the purpose of ascertaining the eligibility of shareholders entitled for Sub-division/Split of 1 Equity share of the Company having face value of Rs 2 each into 2 Equity shares having face value of Re 1 each.
The above information is a part of company’s filings submitted to BSE.
